Akers Biosciences (AKER) –
-
Contango Oil & Gas (MCF) Announces the Appointment of Two New Directors
-
Contango Announces the Appointment of Two New Directors
-
Form 8-K Akers Biosciences, Inc. For: Apr 15
-
Akers Biosciences (AKER), MyMD Pharmaceuticals Announce Stockholder Approval of Merger
-
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
-
Form 425 Akers Biosciences, Inc. Filed by: Akers Biosciences, Inc.
-
Akers Biosciences (AKER) Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial
-
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial
-
Form 425 Akers Biosciences, Inc. Filed by: Akers Biosciences, Inc.
-
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board
-
Form S-3 Akers Biosciences, Inc.
-
Form EFFECT Akers Biosciences, Inc.
-
Form 424B3 Akers Biosciences, Inc.
-
Form 425 Akers Biosciences, Inc. Filed by: Akers Biosciences, Inc.
-
Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals
-
Form 8-K Akers Biosciences, Inc. For: Mar 18
-
Form S-4/A Akers Biosciences, Inc.
-
Form 10-K Akers Biosciences, Inc. For: Dec 31
-
MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery
-
Form SC 13G/A Akers Biosciences, Inc. Filed by: Iroquois Capital Management, LLC
-
Form SC 13G Akers Biosciences, Inc. Filed by: MAINFIELD ENTERPRISES INC
-
Form 425 Akers Biosciences, Inc. Filed by: Akers Biosciences, Inc.
-
Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission
-
Akers Biosciences (AKER) Says Has Not Scheduled Any Earnings Calls
-
Akers Biosciences Responds to Erroneous Earnings Call Press Release
-
Form 3 Akers Biosciences, Inc. For: Feb 01 Filed by: RHODES IAN
-
AKERS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AKER and Encourages Investors to Contact the Firm
-
Form 8-K Akers Biosciences, Inc. For: Jan 28
-
Form SC 13G/A Akers Biosciences, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
-
Form 8-K/A Akers Biosciences, Inc. For: Aug 27
-
Form S-4 Akers Biosciences, Inc.
-
Form 425 Akers Biosciences, Inc. Filed by: Akers Biosciences, Inc.
-
Akers Biosciences (AKER) Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent
-
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent
-
Form D Akers Biosciences, Inc.
-
Form 8-K Akers Biosciences, Inc. For: Nov 20
-
Form SC 13G Akers Biosciences, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
-
Form 425 Akers Biosciences, Inc. Filed by: Akers Biosciences, Inc.
-
Form SC 13G/A Akers Biosciences, Inc. Filed by: Iroquois Capital Management, LLC
-
Form 8-K Akers Biosciences, Inc. For: Nov 18
-
Form 425 Akers Biosciences, Inc. Filed by: Akers Biosciences, Inc.
-
Form 425 Akers Biosciences, Inc. Filed by: Akers Biosciences, Inc.
-
Form 8-K Akers Biosciences, Inc. For: Nov 17
-
REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals
-
Form 10-Q Akers Biosciences, Inc. For: Sep 30
-
Form 8-K Akers Biosciences, Inc. For: Nov 13
-
Form 8-K/A Akers Biosciences, Inc. For: Nov 11
-
Form 8-K Akers Biosciences, Inc. For: Nov 11
-
Akers Biosciences (AKER) Halted on New Desseminated
-
Akers Biosciences (AKER) and MyMD Pharmaceuticals Sign Definitive Merger Agreement
Back to AKER Stock Lookup